The management and survival outcomes of nasopharyngeal cancer in the Nordic countries*

Authors

  • A. Mäkitie Department of Otorhinolaryngology – Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;  Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
  • M. Ruuskanen Department of Otorhinolaryngology – Head and Neck Surgery, Turku University Hospital, Turku, Finland
  • J. Bentzen Department of Oncology, Herlev University Hospital, Copenhagen, Denmark
  • E. Brun Department of Oncology, Skane University Hospital, Lund University, Sweden
  • M. Gebre-Medhin Department of Oncology, Skane University Hospital, Lund University, Sweden
  • S. Friesland Department of Oncology, Karolinska University Hospital, Stockholm, Sweden
  • E. Marsk Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
  • L. Hammarstedt-Nordenvall ivision of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
  • E. Gille Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
  • J. Reizenstein Department of Oncology, Örebro University Hospital, Örebro, Sweden
  • G. Adell Department of Oncology, Linköping University Hospital, Linköping, Sweden
  • L. Farnebo Department of Otorhinolaryngology – Head and Neck Surgery, Linköping University Hospital, Linköping, Sweden
  • J. Rzepecki Department of Oncology, Linköping University Hospital, Linköping, Sweden
  • H. Haugen Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
  • K. Söderström Department of Radiation Sciences, Umeå University, Umeå, Sweden
  • B. Zackrisson Department of Radiation Sciences, Umeå University, Umeå, Sweden
  • S. Bergström Department of Oncology, Gävle Hospital, Gävle, Sweden
  • B. Lödén Department of Oncology, Karlstad Hospital, Karlstad, Sweden
  • L. Cederblad Department of Oncology, Uppsala University Hospital, Uppsala, Sweden
  • G. Laurell Department of Otorhinolaryngology – Head and Neck Surgery, Uppsala University Hospital, Uppsala, Sweden
  • E. Smeland Department of Oncology, University Hospital North Norway, Tromsoe, Norway
  • J. Folkvard Evensen Department of Oncology, Oslo University Hospital, Oslo, Norway
  • J. Å. Lund Department of Oncology, Trondheim University Hospital, Trondheim, Norway
  • H. Tøndel Department of Oncology, Trondheim University Hospital, Trondheim, Norway
  • Å. Karlsdottir Department of Oncology, Haukeland University Hospital, Bergen, Norway
  • J. Jóhannsson Department of Oncology, Landspitali University Hospital, Reykjavik, Iceland
  • J. Johansen Department of Oncology, Odense University Hospital, Odense, Denmark
  • C. A. Kristensen Department of Oncology, The Finsen Centre, Rigshospitalet, Copenhagen, Denmark
  • K. Jensen Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • L. J. Andersen Department of Oncology, Aalborg Hospital, Aalborg, Denmark
  • P. Koivunen Department of Otorhinolaryngology – Head and Neck Surgery, Oulu University Hospital, Oulu, Finland
  • M. Korpela Department of Oncology, Oulu University Hospital, Oulu, Finland
  • L. Voutilainen Department of Oncology, Kuopio University Hospital, Kuopio, Finland
  • T. Wigren Department of Oncology, Tampere University Hospital, Tampere, Finland
  • H. Minn Department of Oncology, Turku University Hospital, Turku, Finland
  • H. Joensuu Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
  • J. Overgaard Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
  • K. Saarilahti Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

DOI:

https://doi.org/10.1080/0284186X.2017.1408961

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2018-04-03

How to Cite

Mäkitie, A., Ruuskanen, M., Bentzen, J., Brun, E., Gebre-Medhin, M., Friesland, S., … Saarilahti, K. (2018). The management and survival outcomes of nasopharyngeal cancer in the Nordic countries*. Acta Oncologica, 57(4), 557–560. https://doi.org/10.1080/0284186X.2017.1408961

Issue

Vol. 57 No. 4 (2018): Acta Oncologica

Section

Articles